David R. Epstein - 12 May 2021 Form 4 Insider Report for Rubius Therapeutics, Inc.

Role
Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 20:35:58 UTC
Next filing
20 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +27,919 $0.000000 27,919 12 May 2021 Common Stock 27,919 $23.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested at the time of grant.